The global vitamin K2 market is growing at a CAGR of 29.7% from 2022 to 2030.Pune, India, Oct. 16, 2023 (GLOBE NEWSWIRE) Vitamin K2, also known as menaquinone, is a part of vitamin K family. It plays an important role in keeping bones and heart healthy. MK-4 and MK-7 are the main isomers that are found to be most beneficial. Adequate intake of vitamin K2 is associated with lower risk of vascular damage because it activates matrix GLA protein (MGP) and activates osteocalcin. MGP inhibits blood
In soon-to-be published research by Gnosis by Lesaffre, new findings suggest that daily intakes of MenaQ7 vitamin K supplement may improve blood vessel elasticity and regulate blood pressure in menopausal women with arterial stiffness.
A new RCT highlights that following supplementation with vitamin K2 (MK-7) in patients with haemodialysis (HD), there were decreases in measures of arterial stiffness which were more pronounced in those with diabetes, compared to those receiving standard care alone.
A pilot study involving 12 patients with chronic kidney disease suggests supplementation surpasses a vitamin-rich diet in improving vit K levels in individuals who are susceptible to deficiency.